Cellebrite DI (CLBT) Research & Development (2020 - 2025)

Cellebrite DI's Research & Development history runs 6 years deep, the most recent figure standing at $29.9 million for Q4 2025.

• On a quarterly basis, Research & Development rose 16.66% year-over-year to $29.9 million in Q4 2025; TTM through Dec 2025 was $113.9 million, a 15.71% increase from a year earlier, with the FY2025 full-year figure at $154.8 million, up 57.31% from the prior year.
• Research & Development climbed to $29.9 million in Q4 2025 per CLBT's latest filing, from $28.1 million in the prior quarter.
• Across five years, Research & Development topped out at $29.9 million in Q4 2025 and bottomed at $14.9 million in Q1 2021.
• The 5-year median for Research & Development is $21.4 million (2022), against an average of $22.1 million.
• Across the five-year window, Research & Development soared 31.7% in 2022 and fell 5.47% in 2023, its largest moves.
• Year by year, Research & Development stood at $18.8 million in 2021, then advanced by 4.78% to $19.7 million in 2022, then grew by 10.22% to $21.8 million in 2023, then increased by 17.69% to $25.6 million in 2024, then rose by 16.66% to $29.9 million in 2025.
• Per Business Quant, the three latest CLBT Research & Development figures stand at $29.9 million (Q4 2025), $28.1 million (Q3 2025), and $28.6 million (Q2 2025).